NDC 52244-404

SEMPREX D

Acrivastine And Pseudoephedrine Hydrochloride

SEMPREX D is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Endo Pharmaceuticals Inc.. The primary component is Acrivastine; Pseudoephedrine Hydrochloride.

Product ID52244-404_21d2a8a6-108c-4c1d-b1ee-c14f6f2dadc6
NDC52244-404
Product TypeHuman Prescription Drug
Proprietary NameSEMPREX D
Generic NameAcrivastine And Pseudoephedrine Hydrochloride
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2012-01-26
Marketing End Date2020-12-31
Marketing CategoryNDA / NDA
Application NumberNDA019806
Labeler NameEndo Pharmaceuticals Inc.
Substance NameACRIVASTINE; PSEUDOEPHEDRINE HYDROCHLORIDE
Active Ingredient Strength8 mg/1; mg/1
Pharm ClassesHistamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC],Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC]
NDC Exclude FlagN

Packaging

NDC 52244-404-10

100 CAPSULE in 1 BOTTLE, PLASTIC (52244-404-10)
Marketing Start Date2012-01-26
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 52244-404-10 [52244040410]

SEMPREX D CAPSULE
Marketing CategoryNDA
Application NumberNDA019806
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-01-26

Drug Details

Active Ingredients

IngredientStrength
ACRIVASTINE8 mg/1

OpenFDA Data

SPL SET ID:d86c6a13-9e5f-43c2-92f5-c7ed7bfcedfc
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1112244
  • 1112246
  • UPC Code
  • 0352244404107
  • Pharmacological Class

    • Histamine H1 Receptor Antagonists [MoA]
    • Histamine-1 Receptor Antagonist [EPC]
    • Adrenergic alpha-Agonists [MoA]
    • alpha-Adrenergic Agonist [EPC]
    • Histamine H1 Receptor Antagonists [MoA]
    • Histamine-1 Receptor Antagonist [EPC]
    • Adrenergic alpha-Agonists [MoA]
    • alpha-Adrenergic Agonist [EPC]

    Medicade Reported Pricing

    52244040410 SEMPREX-D 8 MG-60 MG CAPSULE

    Pricing Unit: EA | Drug Type:

    Trademark Results [SEMPREX]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    SEMPREX
    SEMPREX
    78429596 3023249 Live/Registered
    ACTIENT PHARMACEUTICALS LLC
    2004-06-03
    SEMPREX
    SEMPREX
    74338456 1879087 Dead/Cancelled
    Burroughs Wellcome Co.
    1992-12-09
    SEMPREX
    SEMPREX
    73514851 1421747 Live/Registered
    SEMPREX CORPORATION
    1984-12-24

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.